Advertisement

Researcher Supported by ASCO’s Conquer Cancer Foundation Earns Spot in Clinical Cancer Advances 2019 for Lymphoma Trial


Advertisement
Get Permission

THE WORK of nine researchers who have previously received funding from Conquer Cancer is featured in ASCO’s Clinical Cancer Advances 2019. Visit CONQUER.ORG/CCA for more details.

Sattva S. Neelapu, MD

Sattva S. Neelapu, MD

Immunotherapy for Lymphoma

AT THE University of Texas MD Anderson Cancer Center in Houston, Sattva S. Neelapu, MD, led a multicenter study of patients with refractory large B-cell lymphoma who received chimeric antigen receptor (CAR) T-cell immunotherapy.

Patients receiving this therapy had high levels of durable response, with some side effects.

Immunotherapies represent a promising new option for patients. Prior to the discovery, the survival for patients with lymphoma could be measured in months.

© 2019. American Society of Clinical Oncology. All rights reserved.


Advertisement

Advertisement



;
Advertisement